Certified by Founder Lodge
Medicxi
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $75,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
medicxi is a Life Sciences venture capital firm, with offices in London, St. Helier (Jersey) and Geneva.
| Company | Date | Round | Raised |
|---|---|---|---|
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Curevo Vaccine |
March, 19 ,2025 | Series B | $110,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
![에너지엑스 [Energy X]](/uploads/nwYh5oApoe9nj2Z1675255387.png)
